Clinical Trial to Survey Results of Flourish Vaginal Care System for Recurrent Bacterial Vaginosis
NCT03734523 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 38
Last updated 2023-07-18
Summary
Background
Bacterial Vaginosis is the most common vaginal infection in women in their reproductive years and a difficult one to treat. In the United States, the National Health and Nutrition Examination Survey (NHANES), estimated the prevalence of BV was 29 percent in the general population of women aged 14 to 49 years and 50 percent in African-American women. It is characterized by a shift in vaginal flora from an acidic environment due to acid producing lactobacilli to a mixture of anaerobic and facultative microorganisms. BV causes symptoms of vaginal odor, itching, discharge and irritation and can greatly impact a woman's health, quality of life, sexual relations, self-image and well-being. BV has also been associated with an increased risk of preterm labor, STD acquisition and vaginal cuff cellulitis after hysterectomy6. After treatment with antibiotics, recurrences are common. About 15-30% will have recurrence in 3 months7.
Normal vaginal flora is lactobacilli dominant. Lactobacilli maintain vaginal pH in the acidic range and keep the growth of BV associated bacteria at low levels. Lactobacilli also produce proteins with bactericidal activity which help to maintain their dominance. Anything that alters the vaginal flora and changes the pH to a more basic environment may increase the risk of BV.
Currently, there are many sexual lubricants and vaginal moisturizers available on the market. It has recently been shown that many of these are hyperosmolar and it is thought that hyperosmolar lubricants can be damaging to the epithelium and may alter the pH of the vagina. It is postulated that lubricants and moisturizers may predispose to BV by altering the pH of the vagina.
The Flourish Vaginal Care System, by Good Clean Love, includes the following three products:
Restore, a 510K-cleared moisturizing personal lubricant that has been on the market for 3 years. It is available without a prescription. It is formulated to bio-match the vaginal secretions of women with L. crispatus-dominated microbiota. Restore has a pH of 3.7 with racemic 1% lactic acid, and is iso-osmolar with serum. It is, therefore, much less likely to alter the acid base balance of the vagina, and therefore less likely to predispose to BV.
BiopHresh Vaginal Probiotic Suppository, a Bio Matched probiotic homeopathic formulation which provides a clinically-tested combination of lactobacilli including L. crispatus and other strains found in the most stable vaginal microbiome. Research has shown as many as 30% of women do not naturally produce these critical strains of lactobacilli.
Balance Moisturizing Personal Wash is a gentle, pH-balancing cleanser with soothing botanical extracts, formulated with more than 60% premium aloe. It is made without toxic saponifiers found in most bar soaps and OTC cleansers, which tend to disrupt the cell to cell adhesion barrier8.
The aim of this study is to determine if Flourish Vaginal Care System aids in re-establishing and maintaining a healthy vaginal microbiome by restoring the vaginal pH in to the acidic range. The healthiest vaginal environments are characterized by optimal acidic vaginal pH levels, the presence of specific strains of lactobacilli. The secondary aim is to determine if the continued use of Flourish will prevent recurrence of BV over a 6 month period. The third aim is to determine what the vaginal microbiome community state type is after 6 months of Flourish use.
This study is designed to be a pilot/feasibility study. The study will compare the subjects to a historical recurrence risk7. It will also assess the ability of subjects to comply with the protocol.
Conditions
- Bacterial Vaginosis
- Vaginal Flora Imbalance
Interventions
- COMBINATION_PRODUCT
-
Flourish Vaginal Care System
This is not technically an intervention. All women who enroll in the study will be those who have opted to use the Flourish Vaginal Care System. This system is comprised of a vaginal wash (Balance), an intravaginal moisturizing gel (Restore), and a vaginal probiotic supplement (BiopHresh). Balance will be used daily. Restore will be used every other day. BiopHresh will be used twice a week with Restore. All products will be started after the first visit and continue throughout the 6-month study.
Sponsors & Collaborators
-
Concord Hospital
collaborator OTHER -
Vaginal Biome Science
lead OTHER
Principal Investigators
-
Wendy Strgar · Sexual Health & Wellness Institute
Eligibility
- Min Age
- 18 Years
- Max Age
- 52 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-07-01
- Primary Completion
- 2022-02-28
- Completion
- 2022-02-28
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Vaginal Microbiome Transplantation for Recurrent Bacterial Vaginosis
NCT04517487 ·Status: RECRUITING ·Phase: NA
-
Longitudinal Analysis of the Vaginal Microbiome
NCT05383326 ·Status: COMPLETED
-
Comparing NAAT Testing to Standard Methods for the Diagnosis of Vaginitis
NCT02203942 ·Status: COMPLETED
-
Clinical Evaluation of the Click Sexual Health Test for the Detection of Neisseria Gonorrhoeae (NG), Trichomonas Vaginalis (TV), and Chlamydia Trachomatis (CT) in Women
NCT04098900 ·Status: COMPLETED
-
Validity of Patient-Collected Wet Mounts
NCT02641717 ·Status: COMPLETED ·Phase: NA
-
Bacterial Vaginosis Screening at IUD Insertion
NCT00802386 ·Status: COMPLETED
-
Point of Care Diagnosis of Vaginal Infections
NCT06438575 ·Status: COMPLETED ·Phase: NA
-
Point-of-care Tests for Bacterial Vaginosis and Candidosis
NCT04287504 ·Status: UNKNOWN
-
A Comparison of Cotton and Flocked Swabs for Vaginal Self Collection
NCT02785289 ·Status: COMPLETED ·Phase: NA
-
Screening With Tampons: Evaluating Diagnostic Accuracy and HPV and Assessing Participant Views
NCT06154239 ·Status: COMPLETED ·Phase: NA
-
Vaginal Innate Immunity in Normal and HIV-Infected Women
NCT01318304 ·Status: COMPLETED
-
Monoclonal Antibody-based Multipurpose Microbicides
NCT01859195 ·Status: COMPLETED
-
PNA FISH, PCR and Gram Staining for Detection of Bacterial Vaginosis - a Comparative Clinical Study in a Danish IVF Setting
NCT02042352 ·Status: COMPLETED
-
Comparative Performance of a Vaginal Yeast Test
NCT05079711 ·Status: RECRUITING
-
Genomic Tools for Studying the Ecology of the Human Vaginal Microflora
NCT00576797 ·Status: COMPLETED
-
Using Micro Electro Mechanical Systems to Detect the Air of Vaginal Discharge
NCT05557318 ·Status: RECRUITING ·Phase: NA
-
Use of Self-collected Vaginal Swabs as an Innovative Approach to Facilitate Testing for Repeat Chlamydia Infection
NCT00132457 ·Status: COMPLETED ·Phase: NA
-
Clinical Study of a Diagnostic Device for NG, TV and CT in Women
NCT03852316 ·Status: COMPLETED ·Phase: NA
-
Validation of the GenePOC Strep A, C/G Assay for Detecting Group A, C and G β-hemolytic Streptococcus From Throat Swabs.
NCT03422341 ·Status: COMPLETED ·Phase: NA
-
Comparing Specimen Collection Techniques to Screen for Sexually Transmitted Infections in Pregnant Women: A Pilot Study
NCT03877263 ·Status: TERMINATED ·Phase: NA
-
Trichomonas Vaginalis Repeat Infections Among HIV Negative Women
NCT01832480 ·Status: COMPLETED ·Phase: PHASE3
-
General Pre-Trial Screening Protocol for Infectious Diseases Research
NCT06463704 ·Status: RECRUITING
-
Microscopic Images for the Development of a Rapid Vaginitis Diagnostic Device
NCT03585049 ·Status: COMPLETED
-
Patient Self-sampling of HPV to Screen for Cervical Cancer
NCT05600283 ·Status: COMPLETED ·Phase: NA
-
Self-Obtained Vaginal Swabs for Chlamydia and Gonorrhea Testing
NCT01849653 ·Status: COMPLETED